|
1
|
Li G, Wang Z, Ye J, Zhang X, Wu H, Peng J,
Song W, Chen C, Cai S, He Y, et al: Uncontrolled inflammation
induced by AEG-1 promotes gastric cancer and poor prognosis. Cancer
Res. 74:5541–5552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L, Liang H, Wang Y, Gao S, Yin K, Liu
Z, Zheng X, Lv Y, Wang L, Zhang CY, et al: MiRNA-203 suppresses
tumor cell proliferation, migration and invasion by targeting Slug
in gastric cancer. Protein Cell. 7:383–387. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu M, Wang M, Yang F, Tian Y, Cai J, Yang
H, Fu H, Mao F, Zhu W, Qian H, et al: miR-155-5p inhibition
promotes the transition of bone marrow mesenchymal stem cells to
gastric cancer tissue derived MSC-like cells via NF-κB p65
activation. Oncotarget. 7:16567–16580. 2016.PubMed/NCBI
|
|
5
|
Zhang X, Ni Z, Duan Z, Xin Z, Wang H, Tan
J, Wang G and Li F: Overexpression of E2F mRNAs associated with
gastric cancer progression identified by the transcription factor
and miRNA co-regulatory network analysis. PLoS One.
10:e01169792015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang X, Tang J, Zhi X, Xie K, Wang W, Li
Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor
suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway
in gastric cancer. Oncotarget. 6:1605–1617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ,
Yang K, Ting AH and Yi JM: Epigenetically regulated MIR941 and
MIR1247 target gastric cancer cell growth and migration.
Epigenetics. 9:1018–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuo M, Nakada C, Tsukamoto Y, Noguchi
T, Uchida T, Hijiya N, Matsuura K and Moriyama M: miR-29c is
downregulated in gastric carcinomas and regulates cell
proliferation by targeting RCC2. Mol Cancer. 12:152013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu C, Zheng X, Li X, Fesler A, Hu W, Chen
L, Xu B, Wang Q, Tong A, Burke S, et al: Reduction of gastric
cancer proliferation and invasion by miR-15a mediated suppression
of Bmi-1 translation. Oncotarget. 7:14522–14536. 2016.PubMed/NCBI
|
|
10
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the
tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res.
42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Wang W, Su N, Zhu X, Yao J, Gao W,
Hu Z and Sun Y: miR-374a promotes cell proliferation, migration and
invasion by targeting SRCIN1 in gastric cancer. FEBS Lett.
589:407–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakamoto N, Naito Y, Oue N, Sentani K,
Uraoka N, Oo H Zarni, Yanagihara K, Aoyagi K, Sasaki H and Yasui W:
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and
indicates tumor invasiveness and poor prognosis. Cancer Sci.
105:236–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin H, Song P, Su R, Yang G, Dong L, Luo
M, Wang B, Gong B, Liu C, Song W, et al: DNA methylation mediated
down-regulating of MicroRNA-33b and its role in gastric cancer. Sci
Rep. 6:188242016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Li D, Zhang G, Xiong J, Jie Z, Cheng
H, Cao Y, Jiang M, Lin L, Le Z, et al: Methylation-associated
silencing of MicroRNA-335 contributes tumor cell invasion and
migration by interacting with RASA1 in gastric cancer. Am J Cancer
Res. 4:648–662. 2014.PubMed/NCBI
|
|
15
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan JJ, Zhang YN, Liao JZ, Ke KP, Chang Y,
Li PY, Wang M, Lin JS and He XX: miR-497 suppresses angiogenesis
and metastasis of hepatocellular carcinoma by inhibiting VEGFA and
AEG-1. Oncotarget. 6:29527–29542. 2015.PubMed/NCBI
|
|
17
|
Wang W, Ren F, Wu Q, Jiang D, Li H and Shi
H: MicroRNA-497 suppresses angiogenesis by targeting vascular
endothelial growth factor A through the PI3K/AKT and MAPK/ERK
pathways in ovarian cancer. Oncol Rep. 32:2127–2133.
2014.PubMed/NCBI
|
|
18
|
Jiang Y, Meng Q, Qi J, Shen H and Sun S:
miR-497 promotes metastasis of colorectal cancer cells through
Nrdp1 inhibition. Tumour Biol. 36:7641–7647. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wald AI, Hoskins EE, Wells SI, Ferris RL
and Khan SA: Alteration of microRNA profiles in squamous cell
carcinoma of the head and neck cell lines by human papillomavirus.
Head Neck. 33:504–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Zhang J, Li Y, Wang L, Sui B and
Dai D: miR-455-5p acts as a novel tumor suppressor in gastric
cancer by down-regulating RAB18. Gene. 592:308–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo
M, Dong L, Yin H, Gong B, Li Z, et al: MicroRNA-10a is
down-regulated by DNA methylation and functions as a tumor
suppressor in gastric cancer cells. PLoS One. 9:e880572014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei H, Zou D, Li Z, Luo M, Dong L, Wang B,
Yin H, Ma Y, Liu C, Wang F, et al: MicroRNA-219-2-3p functions as a
tumor suppressor in gastric cancer and is regulated by DNA
methylation. PLoS One. 8:e603692013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY, et al:
MicroRNA-196a/-196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Xia Y, Li L and Zhang G: miR-101
inhibits cell growth and tumorigenesis of Helicobacter pylori
related gastric cancer by repression of SOCS2. Cancer Biol Ther.
16:160–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lehmann U, Streichert T, Otto B, Albat C,
Hasemeier B, Christgen H, Schipper E, Hille U, Kreipe HH and Länger
F: Identification of differentially expressed microRNAs in human
male breast cancer. BMC Cancer. 10:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang
Y, Zou C, Zhang X, Liu S, Wang X, et al: Analysis of miR-195 and
miR-497 expression, regulation and role in breast cancer. Clin
Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang
Y, Yang C and Jiang Y: miR-497 and miR-34a retard lung cancer
growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget.
6:13149–13163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang
B, Shu Y and Liu P: miR-497 modulates multidrug resistance of human
cancer cell lines by targeting BCL2. Med Oncol. 29:384–391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li W, Jin X, Deng X, Zhang G, Zhang B and
Ma L: The putative tumor suppressor microRNA-497 modulates gastric
cancer cell proliferation and invasion by repressing eIF4E. Biochem
Biophys Res Commun. 449:235–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye Z, Shen N, Weng Y, Li K, Hu L, Liao H,
An J, Liu L, Lao S and Cai S: Low miR-145 silenced by DNA
methylation promotes NSCLC cell proliferation, migration and
invasion by targeting mucin 1. Cancer Biol Ther. 16:1071–1079.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL and Dahiya R: Genistein downregulates
onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation
and histone modification in prostate cancer cells. Br J Cancer.
110:1645–1654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao J, Song Y, Bi N, Shen J, Liu W, Fan J,
Sun G, Tong T, He J, Shi Y, et al: DNA methylation-mediated
repression of miR-886-3p predicts poor outcome of human small cell
lung cancer. Cancer Res. 73:3326–3335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cianci P, Tono V, Sala A, Locatelli L,
Carta C, Rizzari C, Biondi A and Selicorni A: A boy with Burkitt
lymphoma associated with Noonan syndrome due to a mutation in RAF1.
Am J Med Genet A. 161A:1401–1404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ren G, Liu X, Mao X, Zhang Y, Stankiewicz
E, Hylands L, Song R, Berney DM, Clark J, Cooper C, et al:
Identification of frequent BRAF copy number gain and alterations of
RAF genes in Chinese prostate cancer. Genes Chromosomes Cancer.
51:1014–1023. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Albers C, Illert AL, Miething C, Leischner
H, Thiede M, Peschel C and Duyster J: An RNAi-based system for
loss-of-function analysis identifies Raf1 as a crucial mediator of
BCR-ABL-driven leukemogenesis. Blood. 118:2200–2210. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Stevens PD, Liu J, Yang H, Wang W,
Wang C, Zeng Z, Schmidt MD, Yang M, Lee EY, et al: PHLPP is a
negative regulator of RAF1, which reduces colorectal cancer cell
motility and prevents tumor progression in mice. Gastroenterology.
146:1301–12.e1, 10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu ZH, Hang JB, Hu JA and Gao BL:
RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to
erlotinib. Int J Clin Exp Pathol. 6:1493–1504. 2013.PubMed/NCBI
|
|
38
|
Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu
Z, Liu T and Hu F: miR-195 is a key regulator of Raf1 in thyroid
cancer. Onco Targets Ther. 8:3021–3028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Z, Liu Y, Li L, Xu Z, Bi B, Wang Y and
Li JY: miR-7-5p is frequently downregulated in glioblastoma
microvasculature and inhibits vascular endothelial cell
proliferation by targeting RAF1. Tumour Biol. 35:10177–10184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
